FDA Authorizes Emergency Use for Monoclonal Antibody Drug Amid $720 Million Deal

Contact Your Elected Officials
The Epoch Times Header

The Food and Drug Administration (FDA) on Friday announced it handed down an emergency use authorization for Eli Lilly and Company’s bebtelovimab, a monoclonal antibody treatment for COVID-19.

The drug is intended for the treatment of mild to moderate COVID-19, the illness caused by the CCP (Chinese Communist Party) virus in patients aged 12 and older who tested positive for COVID-19 and are “at high risk for progression to severe” disease, including hospitalization or death.

It also applies to individuals for which “alternative COVID-19 treatment options approved or authorized by the FDA are not accessible or clinically appropriate,” according to an FDA news release.

“Bebtelovimab is not authorized for patients who are hospitalized due to COVID-19 or require oxygen therapy due to COVID-19,” said the federal drug regulator. “Treatment with bebtelovimab has not been studied in patients hospitalized due to COVID-19. Monoclonal antibodies, such as bebtelovimab, may be associated with worse clinical outcomes when administered to hospitalized patients with COVID-19 requiring high flow oxygen or mechanical ventilation.”

The agency and Eli Lilly said that bebtelovimab works by binding with the CCP virus spike protein that causes COVID-19 and is similar to other monoclonal antibodies that have been approved by the FDA and other drug regulators.

Meanwhile, the drug also appears to work against the Omicron subvariant BA.2, which some researchers have said is more contagious than the initial strain, according to the agency.

COVID-19-related hospitalizations and deaths through day 29 for those who received bebtelovimab alone or with other monoclonal antibodies were lower than the placebo rate in previous trials of the drug, the FDA and Eli Lilly said.

“Today’s action makes available another monoclonal antibody that shows activity against omicron, at a time when we are seeking to further increase supply,” said Patrizia Cavazzoni, M.D, director of the FDA’s Center for Drug Evaluation and Research, in the release. “This authorization is an important step in meeting the need for more tools to treat patients as new variants of the virus continue to emerge.”

Eli Lilly, in a statement released on Feb. 10, announced that it came to an agreement with the federal government to supply 600,000 doses of the drug for $720 million.

“The supply agreement calls for the delivery of up to 600,000 doses no later than March 31, 2022 with an option of 500,000 additional doses no later than July 31, 2022,” according to the company.

The FDA said that potential side effects include itching, rash, nausea, vomiting, and infusion-related reactions.

By Jack Phillips

Read Original Article on TheEpochTimes.com

The Epoch Times
The Epoch Timeshttps://www.theepochtimes.com/
Tired of biased news? The Epoch Times is truthful, factual news that other media outlets don't report. No spin. No agenda. Just honest journalism like it used to be.

Trump’s Middle East Triumph is Worth Celebrating Even As Peace Remains Elusive 

President Trump’s bold foreign policy defies globalist appeasement, showcasing unwavering American strength and decisive leadership on the world stage.

Are conservatives fighting a fiction of woke?

Wokery, it hurts to say it, is too disorganized to have an organized cosmology or doctrine of metaphysical belief.

Illinois Democrat Offenders Reveal Party

The crime of J.B Pritzker and Brandon Johnson in this episode of American history is called subversion at the least , but could be as serious as treason.

Inside the Public School Librarian Jihad to Keep Transgender Propaganda on Shelves

Public school librarians are doing all they can to keep child tranny propaganda flowing directly into the malleable minds of their charges.

Five Reasons Why The Latest Czech Elections Were So Important

Populist-nationalist politician Andrej Babis is poised to return to the premiership after his party's victory. Here are 5 reasons why this is so important.

New York AG Letitia James Indicted on Federal Charges

New York Attorney General Letitia James was indicted by a grand jury on federal charges, according to an indictment on unsealed on Thursday.

6 Ways Vaccine Policy Has Changed Under RFK Jr.

Health Sec RFK, Jr. and officials at the HHS changed recommendations and policies for multiple vaccines, including shots against COVID-19 and measles.

Journalists Recount Antifa Violence in Roundtable With Trump

President Trump met at the White House with journalists attacked by the newly designated terrorist group Antifa, joined by Cabinet officials for a roundtable.

IRS to Furlough 34,000 Employees as Government Shutdown Halts Treasury Operations

The IRS said in an emergency message to staff that it will furlough more than 34,000 employees starting on Oct. 8 due to the government shutdown.

Trump Says He May Invoke Insurrection Act in Portland If Necessary

President Donald Trump on Oct. 6 said he may consider invoking the Insurrection Act in Portland, Oregon, if necessary.

Trump: All Medium, Heavy Duty Trucks Entering US Will See 25 Percent Tariff on Nov. 1

President Trump announced on Monday that all medium and heavy-duty trucks entering the United States will see a 25 percent tariff starting on Nov. 1.

Treasury Names Social Security Commissioner as CEO of IRS

Treasury Sec. Scott Bessent announced that Frank Bisignano, the head of the Social Security Administration (SSA), will also serve as CEO of the IRS.

Agencies Terminated, Descoped 94 Wasteful Contracts With $8.5 Billion Ceiling Value, Says DOGE

Various federal government agencies have terminated and descoped 94 wasteful contracts over the past five days, DOGE said in an Oct. 4 post on X.
spot_img

Related Articles

Popular Categories

MAGA Business Central